GluN2B ‐Derived Small Interfering Peptide ( GluN2B ‐Sip) Protects Against Sevoflurane‐Induced Neurotoxicity in Developing Rats
Journal of Neurochemistry · 2025
DOI: 10.1111/jnc.70118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Kun Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Brain Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Sevoflurane, Receptors, N-Methyl-D-Aspartate, Anesthetics, Inhalation, Neuroprotective Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: The Science and Technology Planning Project of Guangzhou, China, The Natural Science Foundation of Guangdong Province, China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Sevoflurane is widely used in pediatric anesthesia due to its rapid induction, minimal airway irritation, and stable hemodynamics. However, concerns have been raised regarding its potential adverse effects on cognition. Recent studies suggest that GluN2B‐containing NMDA receptors play a key role in the memory deficits associated with sevoflurane exposure. In this study, we investigated whether the GluN2B small interfering peptide (GluN2B‐sip) could protect against neurotoxicity induced by neonatal sevoflurane exposure. Our findings show that neonatal sevoflurane exposure leads to an increase in apoptosis‐related proteins, long‐term memory impairment, and reduced levels of synaptic proteins in the hippocampus of adolescent rats. GluN2B‐sip partially restored synapse development and cognitive function. Together, these results suggest that GluN2B‐sip mitigates sevoflurane‐induced neurodegeneration and cognitive impairment in developing rats, providing a potential therapeutic strategy to prevent sevoflurane neurotoxicity. The Cdk5/GluN2B and Cdk5/CRMP2 signaling pathways may play central roles in this protective effect. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Brain Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
- Guangdong Province Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
- Guangdong Province Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Yafang Liu
Förderung
- The Science and Technology Planning Project of Guangzhou, China
- The Natural Science Foundation of Guangdong Province, China
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Zhang, K., Liu, Y., Liao, Z., Zhang, M., Zhang, J., & Li, Y. (2025). GluN2B ‐Derived Small Interfering Peptide ( GluN2B ‐Sip) Protects Against Sevoflurane‐Induced Neurotoxicity in Developing Rats. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70118
Vancouver
Zhang K, Liu Y, Liao Z, Zhang M, Zhang J, Li Y. GluN2B ‐Derived Small Interfering Peptide ( GluN2B ‐Sip) Protects Against Sevoflurane‐Induced Neurotoxicity in Developing Rats. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70118
BibTeX
@article{Zhang2025,
author = {Zhang, Kun and Liu, Yafang and Liao, Zhaoxia and Zhang, Mingfang and Zhang, Jing and Li, Yujuan},
title = {GluN2B ‐Derived Small Interfering Peptide ( GluN2B ‐Sip) Protects Against Sevoflurane‐Induced Neurotoxicity in Developing Rats},
journal = {Journal of Neurochemistry},
year = {2025},
doi = {10.1111/jnc.70118}
}
EUVIMED